Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intestinal Neoplasms × Artesunate × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Malaria 1 Lymphoma, Follicular 1 Intestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Irinotecan 3 Fluorouracil 3 Bevacizumab 3 Oxaliplatin 2 Leucovorin 2 Capecitabine 2 Bisacodyl 2 Aspirin 2 lutetium Lu 177 dotatate 1 guadecitabine 1 copper dotatate CU-64 1 camrelizumab 1 apatinib 1 XELOX 1 Ursodeoxycholic Acid 1 Trastuzumab 1 Simvastatin 1 Radiotherapy 1 Polyethylene Glycols 1 Oviposition 1 Lutetium-177 1 Lutetium 1 Ileostomy 1 Drainage 1 Cyclophosphamide 1 Colonoscopy 1 Chemoradiotherapy 1 Celecoxib 1 Cathartics 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02633098 2022-10-12

NeoART

St George's, University of London

Phase 2 Unknown

Gastrointestinal

Intestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡